Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;15(4):e003533.
doi: 10.1161/CIRCGEN.121.003533. Epub 2022 May 24.

Risk of Congenital Heart Defects in Offspring of Affected Mothers and Fathers

Affiliations

Risk of Congenital Heart Defects in Offspring of Affected Mothers and Fathers

Nina Øyen et al. Circ Genom Precis Med. 2022 Aug.

Abstract

Background: Smaller studies have reported a higher offspring risk of congenital heart defects (CHDs) for mothers with CHDs than for fathers with CHDs. In a large population-based study, we investigated whether offspring risk of CHD differed for mothers and fathers with CHDs.

Methods: All people born in Denmark, 1977 to 2011, with at least 1 registered parent, were included in our cohort (n=2 341 061). Parent-child recurrence of CHDs was evaluated using risk ratios (RRs) comparing risks of CHDs in individuals with and without a parent with a CHD, estimated using log-linear binomial regression.

Results: The RRs for any CHD in offspring were 5.39 (95% CI, 4.88-5.96) for mothers and 3.04 (95% CI, 2.59-3.57) for fathers affected with any CHD; the ratio of RRs for mothers versus fathers was 1.82 (P<0.0001). Recurrence RRs for the same cardiac phenotype in parent and offspring were significantly stronger for mothers than for fathers for conotruncal defects (ratio of RRs, 4.98), left ventricular outlet tract obstruction (ratio of RRs, 4.98), and ventricular septal defects (ratio of RRs, 2.51) but not for atrioventricular septal defects (ratio of RRs, 1.06). Birth rates among people with CHDs, relative to the general population, were 18% higher for women than for men, regardless of parental cardiac phenotype.

Conclusions: Recurrence risks of CHDs were significantly greater in the offspring of affected women than in the offspring of affected men. The excess maternal recurrence risks could not be explained by the slightly higher birth rates in women with CHDs.

Keywords: birth rate; cohort studies; epidemiology; genetics; heart defects, congenital; population; risk.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Concordant cardiac phenotype in parent and offspring. Risk ratios (RRs) for congenital heart defects in offspring for concordant cardiac phenotypes for mother-offspring recurrence (red circles) and father-offspring recurrence (blue squares) among 2 341 061 singleton births in Denmark, 1977 to 2011. RRs with 95% CIs adjusted for year of birth and congenital heart defects in other family members (first-, second-, and third-degree relatives) in log-linear binomial regression analyses. A, Any concordant congenital cardiac defect overall (Any, same phenotype); left ventricular outflow tract obstruction (LVOTO); right ventricular outflow tract obstruction (RVOTO); any septal defect (Septal (any)); atrial septum defect (ASD); ventricular septum defect (VSD); valve defect (Valve); other specified cardiac defect (Other specified); and unspecified cardiac defect (Unspecified). B, Heterotaxy; conotruncal cardiac defect (Conotruncal); and atrioventricular septum defect (AVSD). There are no estimates for heterotaxia and RVOTO for father-offspring recurrence because there were no pairs where both father and child were affected.
Figure 2.
Figure 2.
Forest plot with female birth rate ratios and male birth rate ratios among individuals with congenital heart defects relative to the general population* adjusted for age and period. APVR indicates anomalous pulmonary venous return; ASD, atrial septum defect; AVSD, atrioventricular septum defect; LVOTO, left ventricular outflow tract obstruction; PDA, persistent ductus arteriosus; RR, risk ratio; RVOTO, right ventricular outflow tract obstruction; and VSD, ventricular septum defect. *Birth rate ratios for women with congenital heart defects (relative to the birth rate in the general female population) and men with congenital heart defects (relative to the birth rate in the general male population) among 1 635 823 women and 1 692 165 men born in Denmark in or after 1970.
Figure 3.
Figure 3.
Congenital heart defects: mother/father ratio of recurrence risks in offspring (y axis) by female/male ratio of birth rate ratios (x axis). Plot of the ratio of the female birth rate ratio and the male birth rate ratio among individuals with congenital heart defects relative to the general population* (x axis) and the ratio between the mother-offspring risk ratio and the father-offspring risk ratio for congenital heart defects† (y axis). ASD indicates atrial septum defect; AVSD, atrioventricular septum defect; LVOTO, left ventricular outflow tract obstruction; PDA, persistent ductus arteriosus; and VSD, ventricular septum defect. *The ratio compared birth rate ratios for women with congenital heart defects (relative to the birth rate in the general female population) and men with congenital heart defects (relative to the birth rate in the general male population) in 1 635 823 women and 1 692 165 men born in Denmark in or after 1970. †The ratio compared the offspring heart defect recurrence risk for women with congenital heart defects (relative to the offspring heart defect risk in unaffected mothers) and the offspring heart defect recurrence risk for men with congenital heart defects (relative to the offspring heart defect risk in unaffected fathers), in 2 341 061 singleton births in Denmark, 1977 to 2011.

Comment in

References

    1. Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro RV, McGuire AL, Mital S, Priest JR, Pu WT, Roberts A, et al. ; American Heart Association Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association. Circulation. 2018;138:e653–e711. doi: 10.1161/CIR.0000000000000606 - PMC - PubMed
    1. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, et al. ; ESC Scientific Document Group. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42:563–645. doi: 10.1093/eurheartj/ehaa554 - PubMed
    1. Nora JJ, Nora AH. Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol. 1987;59:459–463. doi: 10.1016/0002-9149(87)90956-8 - PubMed
    1. Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, Dennis NR, Allan L, Arnold R, Deanfield JE, et al. . Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet. 1998;351:311–316. doi: 10.1016/s0140-6736(97)06486-6 - PubMed
    1. Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. Recurrence of congenital heart defects in families. Circulation. 2009;120:295–301. doi: 10.1161/CIRCULATIONAHA.109.857987 - PubMed

Publication types